Pulmonary Responses Following Quercetin Administration in Rats After Intratracheal Instillation of Amiodarone
Kulcsszavak:
Amiodarone, Quercetin, Pulmonary inflammation, Bronchoalveolar lavage fluid, Intra-tracheal instillationAbsztrakt
Summary: Amiodarone, a drug that treats arrhythmias induces pulmonary toxicity through interplay between oxidative stress and inflammation. Quercetin, a flavonoid widely occurring in natural products possesses antioxidant and anti-inflammatory properties. The aim of the present study was to evaluate the effects of quercetin on pulmonary responses in rats after amiodarone intra-tracheal instillation. Eighteen female Wistar rats (150-250 g) were randomly assigned into three groups of six animals each namely; control, amiodarone (AMI) and amiodarone + Quercetin (AMI + Quercetin) groups. AMI group received 2 intra-tracheal instillations of amiodarone (6.25mg/kg in 0.3ml of water) on days 0 and 2 and 0.4ml of 2% DMSO (Dimethyl sulfoxide) orally from day 0 for 3 weeks. AMI + Quercetin group was administered 2 intratracheal instillations of amiodarone on days 0 and 2 and 20mg/kg body weight of quercetin in 2% DMSO from day 0 for 3 weeks. Thereafter, the animals were sacrificed and bronchoalveolar lavage fluid (BALF) was collected to determine total cell polymorphonuclear (PMN) cell and macrophage counts. Inflammation of the lung tissues was also assessed. Macrophage count of AMI + Quercetin group was significantly lowered (p<0.01) compared to AMI group. Inflammation rate of the AMI + Quercetin group was significantly reduced compared to AMI group (p<0.01). Quercetin treatment markedly suppressed amiodarone induced toxicity in the pulmonary tissues.
Hivatkozások
Aasbo, J.D., Lawrence, A.T., Krishnan, K., Kim, M.H., Trohman, R.G. (2005). Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: A Meta- analysis. Annals of Internal Medicine, 143: 327-336. Al-Shammari, B., Khalifa, M., Bakheet, S.A., Yasser, M. (2016). A mechanistic study on the amiodarone-induced pulmonary toxicity. Oxidative Medicine and Cellular Longevity. 2016: Article ID: 6265853. doi:10.1155/2016/6265853. Boots, A.W., Haenen, G.R., Bast, A. (2008). Health effects of quercetin: from antioxidant to nutraceutical. European Journal of Pharmacology. 585: 325-337. Chen, D., and Hedges, T.R. (2003). Amiodarone optic neuropathy-review. Seminars in Ophthalmology. 18: 169- 173. Driscoll, K.E., Costa, D.L., Hatch, G., Henderson R., Oberdorster G., Salem H., Schlesinger R. B. (2000). Intra-tracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicological Sciences. 55: 24-35. El-Mohandes, E.M., Moustafa, A.M., Khalaf, H.A., Hassan, Y.F. (2017). The role of mast cells and fibrosis and the possible attenuating role of ator vastatin. Biotechnology and Histochemistry 92: 467- 480. Feitelson, M.A., Arzumanyan, A., Kulathinal, R.J, Blain S.W., Holcombe R.F., Mahajna J., Martinez-Chantar M.L., Nawroth R., Sanchez-Garcia I., Sharma D., Saxena N.K., Singh N., Vlachostergios P.J., Guo S., Honoki K., Fujii H., Georgakilas A.G., Bilsland A., Amedei A., Niccolai E., Amin A., Ashraf S.S., Boosani C.S., Guha G., Ciriolo M.R., Aquilano K., Chen S., Mohammed S.I., Azmi A.S., Bhakta D., Halicka D., Keith W.N., Nowsheen S. (2015). Sustained proliferation in cancer: mechanisms and novel therapeutic targets. Seminars in Cancer Biology. 35 Suppl: S25-S54. Formica, J.V., and Regelson, W. (1995). Review of the biology of quercetin and related bioflavonoids. Food and Chemical Toxicology. 33: 1061-1080. González, R., Ballester, I., Lopez-Posadas, R., Suarez M.D., Zarzuelo A., Martinez-Augustin O., Sanchez de Medina F. (2011). Effects of flavonoids and other polyphenols on inflammation. Critical Review of Food Science and Nutrition. 51: 331-362. Halliwell, W. (1997). Cationic amphiphilic drug-induced phospholipidosis. Toxicology and Pathology. 25: 53-60. Hamid-Reza, N., Siyavash, J., Hamid, K., Hamid-Reza, P., Shahriar, D. (2016). Coadministration of Atorvastatin and Amiodarone Increases the Risk of Pulmonary Fibrosis in Rats. Medical Principles and Practice. 25: 150 – 154. Jessurum, G.A., and Crijins, H.J. (1997). Amiodarone pulmonary toxicity. British Medical Journal. 314: 619-620. Kerksick, C., Willoughby, D. (2005). The antioxidant role of Glutathione and N-Acetyl-Cysteine supplements and exercise-induced oxidative stress. Journal of the International Society of Sports Nutrition. 2: 38-44. Liu, H., Xue, J., Xing, L., Ao, R., Lu, Y. (2013). Quercetin liposomes protect against radiation-induced pulmonary injury in a murine model. Oncology Letters. 6: 453-459. Madamanchi, N.R., Hakim, Z.K., Runge, M.S. (2005). Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. Journal of Thrombosis and Haemostasis. 3: 254-267. Martin, W.J., Rosenow, E.C. (1998). Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2). Chest. 93: 1242-1246. Mason, J.W. (1987). Amiodarone. The New England Journal of Medicine. 316: 455-466. Murakami, A., Ashida, H., Terao, J. (2008). Multi-targeted cancer prevention by quercetin. Cancer Letters. 269: 315-325. Nacca, N., Bhamidipati, C.M., Yuhico, L.S., Pinnamaneni, S., Szombathy, T. (2012). Severe amiodarone induced pulmonary toxicity. Journal of Thoracic Diseases 4: 667- 670. Nair, M.P., Mahajan, S., Reynolds, J.L., Aalinkeel, R., Nair, H., Schwartz, S.A., Kandaswami C. (2006). The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-Kappa beta system. Clinical and Vaccine Immunology 13: 319-328. Nikfarjam, B.A., Hajiali, F., Adineh, M., Nassiri-Asl, M. (2017). Anti-inflammatory effects of Quercetin and Vitexin on activated human peripheral blood neutrophils. Journal of Pharmacopuncture. 20: 127-131. Ogami, A., Morimoto, Y., Yamato, H., Oyabu, T., Kajiwara, T., Tanaka, I. (2004). Patterns of histopathological change determined by the point counting method and its application for the hazard assessment of respirable dust. Inhalation Toxicology. 16: 793-800. Okada, T., Ogami, A., Lee, B.W., Kadoya, C., Oyabu, T., Myojo, T. (2016). Pulmonary responses in rat lungs after intratracheal instillation of 4 crystal forms of titanium dioxide nanoparticles. Journal of Occupational Health. 58: 602-611. Oostveen, E.M., Stalpers, Bast, A. (2002). Protection of flavonoids against lipid peroxidation: the structure activity relationship revisited. Free Radical Research. 36: 575-581. Pritchard, R.E., Prassinos, A.J., Osborne, J.D., Raviv, Z., Balish, M.F. (2014). Reduction of Hydrogen Peroxide accumulation and toxicityby a catalase from Mycoplasma iowae. PLoS ONE. 9: e105188. Punithavathi, D., Venkatesan, N., Babu, M. (2003). Protective effects of Curcumin against amiodarone-induced pulmonary fibrosisin rats. British Journal of Pharmacology. 139: 1342-1350. Rahma, I. (2002). Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochemical Pharmacology. 64: 935-942. Reasor, M.J., Ogle, C.L., Walker, E.R., Kacew, S. (1988). Amiodarone-induced phopholipidosis in rat alveolar macrophages. American Review of Respiratory Disease. 137: 510-518. Russo, G.L., Russo, M., Spagnuolo, C., Tedesco, I., Bilotto S., Iannitti, R., Palumbo, R. (2014). Quercetin: a pleiotic kinase inhibitor against cancer. Cancer Treatment and Research. 159: 185-205. Shaik, Y.B., Castellani, M.L., Perrella, A., Conti, F., Salini, V., Tete, S., Madhappan, B., Vecchiet, J., De Lutiis, M.A., Caraffa A., Cerulli G. (2006). Role of quercetin (a natural herbal compound) in allergy and inflammation. Journal of Biological Regulators and Homeostatic Agents. 20: 47-52. Ujah, G.A., Nna, V.U., Agah, M.I., Omue, L.O., Leku, C.B., Osim, E.E. (2018). Effect of Quercetin on Cadmium Chloride induced impairments in sexual behaviour and steroidogenesis in male Wistar rats. Andrologia. 50. doi:10.1111/and.12866. Vasallo, P., Trohman, R.G. (2007). Prescribing amiodarone. JAMA. 298: 1312-1322. Williams, R.J., Spencer, J.P., Rice-Evans, C. (2004). Flavonoids: anti-oxidants or signalling molecules. Free Radical Biology & Medicine. 36: 838-849. Wolkove, N., and Baltzan, M. (2009). Amiodarone pulmonary toxicity. Canadian Respiratory Journal 16: 43-48. Zimetbaum, P. (2007). Amiodarone for atrial fibrillation. New England Journal of Medicine. 356: 935-941.
Letöltések
Megjelent
Folyóirat szám
Rovat
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
